Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Apyx Medical
APYX
$128M
| $194K | ﹤0.01% |
92,300
+32,900
| +55% | +$63.6K |
|
|
PLXP
3002
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $192K | ﹤0.01% |
2,138
+413
| +24% | +$39.6K |
|
3003
BCB Bancorp
BCBP
$163M
| $189K | ﹤0.01% |
+18,158
| New | +$190K |
|
|
MOBL
3004
DELISTED
MobileIron, Inc.
MOBL
| $189K | ﹤0.01% |
52,300
-28,523
| -35% | -$112K |
|
|
MCUR
3005
DELISTED
Macrocure Ltd.
MCUR
| $189K | ﹤0.01% |
148,800
+138,100
| +1,291% | +$286K |
|
|
TSRI
3006
DELISTED
TSR Inc. New
TSRI
| $189K | ﹤0.01% |
40,550
+700
| +2% | +$3.17K |
|
|
FABC
3007
Fabric.AI Inc
FABC
$18.3M
| $188K | ﹤0.01% |
9
+3
| +50% | +$69.8K |
|
3008
Universal Safety Products Inc
UUU
$10.3M
| $188K | ﹤0.01% |
42,000
+2,400
| +6% | +$11.8K |
|
|
GMLP
3009
DELISTED
Golar LNG Partners LP
GMLP
| $188K | ﹤0.01% |
14,068
-113,650
| -89% | -$1.71M |
|
3010
Value Line
VALU
$341M
| $186K | ﹤0.01% |
13,100
+1,300
| +11% | +$20K |
|
|
TWER
3011
DELISTED
Towerstream Corporation Common Stock
TWER
| $186K | ﹤0.01% |
24,540
+10,795
| +79% | +$139K |
|
3012
Clarus
CLAR
$145M
| $185K | ﹤0.01% |
41,986
-9,140
| -18% | -$44.9K |
|
3013
Planet Green Holdings
PLAG
$16.1M
| $185K | ﹤0.01% |
607
-1
| -0.2% | -$278 |
|
3014
MiMedx Group
MDXG
$612M
| $184K | ﹤0.01% |
+19,600
| New | +$170K |
|
3015
Mastech Digital
MHH
$95.3M
| $184K | ﹤0.01% |
50,400
+1,800
| +4% | +$7.02K |
|
|
BDMS
3016
DELISTED
BIRNER DENTAL MGMT SVCS INC
BDMS
| $183K | ﹤0.01% |
16,300
+400
| +3% | +$4.86K |
|
3017
Axogen
AXGN
$2.58B
| $182K | ﹤0.01% |
36,400
-42,100
| -54% | -$208K |
|
|
ALIM
3018
DELISTED
Alimera Sciences
ALIM
| $182K | ﹤0.01% |
5,013
-3,464
| -41% | -$150K |
|
3019
Option Care Health
OPCH
$3.61B
| $179K | ﹤0.01% |
+25,555
| New | +$204K |
|
|
CPL
3020
DELISTED
CPFL Energia S.A.
CPL
| $179K | ﹤0.01% |
24,704
-177,110
| -88% | -$1.4M |
|
|
GFN
3021
DELISTED
General Finance Corporation
GFN
| $179K | ﹤0.01% |
44,900
-23,663
| -35% | -$98.3K |
|
3022
Theravance Biopharma
TBPH
$878M
| $178K | ﹤0.01% |
+10,880
| New | +$173K |
|
3023
Lantronix
LTRX
$272M
| $176K | ﹤0.01% |
155,566
+6,400
| +4% | +$7.72K |
|
3024
Northern Technologies International Corp
NTIC
$76.7M
| $176K | ﹤0.01% |
25,400
+400
| +2% | +$3.08K |
|
|
HELI
3025
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
| $176K | ﹤0.01% |
27,759
+9,689
| +54% | +$94.2K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.